Exact Mass: 470.1776376
Exact Mass Matches: 470.1776376
Found 500 metabolites which its exact mass value is equals to given mass value 470.1776376
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Linonin
Linonin, also known as 7,16-dioxo-7,16-dideoxylimondiol or evodin, is a member of the class of compounds known as limonoids. Limonoids are highly oxygenated, modified terpenoids with a prototypical structure either containing or derived from a precursor with a 4,4,8-trimethyl-17-furanylsteroid skeleton. All naturally occurring citrus limonoids contain a furan ring attached to the D-ring, at C-17, as well as oxygen containing functional groups at C-3, C-4, C-7, C-16 and C-17. Linonin is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). Linonin can be found in lemon, which makes linonin a potential biomarker for the consumption of this food product. Limonin is a limonoid, an epoxide, a hexacyclic triterpenoid, a member of furans, an organic heterohexacyclic compound and a lactone. It has a role as a metabolite, an inhibitor and a volatile oil component. Limonin is a natural product found in Citrus tankan, Flacourtia jangomas, and other organisms with data available. Limonin is a triterpenoid compound rich in citrus fruits that has antiviral and antitumor activities. Limonin is a triterpenoid compound rich in citrus fruits that has antiviral and antitumor activities.
Zapoterin
Zapoterin is found in pomes. Zapoterin is a constituent of the seeds of Casimiroa edulis (Mexican apple) Constituent of the seeds of Casimiroa edulis (Mexican apple). Zapoterin is found in pomes.
Butyrylmallotochromene
Limonin
Limonin is found in citrus. Limonin is isolated from oranges and other citrus fruits (Citrus species). Limonin is a limonoid, and a bitter, white, crystalline substance found in orange and lemon seeds. It is also known as limonoate D-ring-lactone and limonoic acid di-delta-lactone. Chemically, it is a member of the class of compounds known as furanolactones Isolated from oranges and other citrus fruits (Citrus subspecies). Limonin is a triterpenoid compound rich in citrus fruits that has antiviral and antitumor activities. Limonin is a triterpenoid compound rich in citrus fruits that has antiviral and antitumor activities.
7-hydroxymethotrexate
7-hydroxymethotrexate is a metabolite of methotrexate. Methotrexate, abbreviated MTX and formerly known as amethopterin, is an antimetabolite and antifolate drug. It is used in treatment of cancer, autoimmune diseases, ectopic pregnancy, and for the induction of medical abortions. It acts by inhibiting the metabolism of folic acid. Methotrexate began to replace the more toxic antifolate aminopterin starting in the 1950s. The drug was developed by Yellapragada Subbarao. (Wikipedia) D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists
3-Carboxylic acid-picumast
C25H27ClN2O5 (470.16084020000005)
Benzyloxycarbonylphenylalanylphenylalanine diazomethyl ketone
C27H26N4O4 (470.19539560000004)
Docarpamine
Imiglitazar
C28H26N2O5 (470.18416260000004)
Mallotophilippen B
A chromenol that is 2H-chromene-5,7-diol substituted by geminal methyl groups at position 2, a 2-methylbutanoyl group at position 8 and a 3-acetyl-2,4,6-trihydroxy-5-methylbenzyl group at position 6. Isolated from Mallotus philippensis, it exhibits anti-inflammatory activity.
Alvaradoin M
A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 3-O-senecioyl-alpha-L-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10S stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.
Alvaradoin L
A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 2-O-senecioyl-alpha-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10S stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.
2-(1,3-Benzodioxol-5-yl)-3,5,6,8-tetramethoxy-7-[(3-methyl-2-butenyl)oxy]-4H-1-benzopyran-4-one
methyl (4bR,10aR,12aS)-6-hydroxy-3,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,5,8-tetraoxo-10b,11-dihydronaphtho[2,1-f]isochromene-4a-carboxylate
6-[2-hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5,7-dimethoxychromen-2-one
(aS,6R,7R,8R)-5,6,7,8-tetrahydro-1,13-dihydroxy-2,3-dimethoxy-6,7-dimethyl-benzo[3,4]cycloocta[1,2:4,5]benzo[1,2-d][1,3]dioxol-8-yl (2Z)-2-methylbut-2-enoate|kadsutherin A
3-Sulfate -(3beta,5beta,11alpha,14beta)-3,5,14-Trihydroxycard-20(22)-enolide
C23H34O8S (470.19742840000004)
4beta-hydroxy-6-O-(p-hydroxybenzoyl)-tetrahydrolinaride|americanoside
(2alpha,3alpha,4beta,5alpha,12R,19alpha)-6,7-didehydro-3,4-dihydroxy-17-methoxy-8-oxo-2,21-cycloaspidospermidine-1,3-dicarboxylic acid dimethyl ester|3-oxo-kopsingine|kopsidarine
5-[4-[2-(3-Hydroxyphenyl)ethyl]phenoxy]-6-methoxy-9,10-dihydrophenanthrene-1,2,7-triol
Limonin
Limonin is a limonoid, an epoxide, a hexacyclic triterpenoid, a member of furans, an organic heterohexacyclic compound and a lactone. It has a role as a metabolite, an inhibitor and a volatile oil component. Limonin is a natural product found in Citrus tankan, Flacourtia jangomas, and other organisms with data available. Limonin is a triterpenoid compound rich in citrus fruits that has antiviral and antitumor activities. Limonin is a triterpenoid compound rich in citrus fruits that has antiviral and antitumor activities.
(2R,3R)-4,5,5,7-tetrahydroxy-3-methoxy-6-[6-hydroxy-3,7-dimethyl-2(E),7-octadienyl]flavanone
5-[2-(6-Hydroxy-4,7-dimethoxy-benzofuran-5-yl)-2-oxo-ethyl]-4-methoxy-6,6-dimethyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-6-ium
4,6-dihydroxy-3-(6-hydroxy-1-oxo-3-pentylisochromen-8-yl)oxy-2-pentylbenzoic acid
3,9-dihydroxy-6-oxo-7-(2-oxoheptyl)-1-pentylbenzo[b][1,4]benzodioxepine-2-carboxylic acid
6-[2-hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5,7-dimethoxychromen-2-one
7-Hydroxymethotrexat
D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists CONFIDENCE standard compound; INTERNAL_ID 2731 CONFIDENCE standard compound; INTERNAL_ID 8505
C26H30O8_4aH-Phenanthro[2,1-c]pyran-4a-carboxylic acid, 1,3,4,4b,5,7,8,10a,10b,11,12,12a-dodecahydro-6-hydroxy-3,4b,7,7,10a,12a-hexamethyl-12-methylene-1,4,5,8-tetraoxo-, methyl ester, (4bR,10aR,12aS)
C26H30O8_3-(1-Acetoxy-3-methylbutyl)-6-{2-hydroxy-4-methyl-6-[(1E)-3-oxo-1-buten-1-yl]phenoxy}-2-methoxybenzoic acid
6-[2-hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5,7-dimethoxychromen-2-one [IIN-based: Match]
4,6-dihydroxy-3-(6-hydroxy-1-oxo-3-pentylisochromen-8-yl)oxy-2-pentylbenzoic acid [IIN-based: Match]
6-[2-hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5,7-dimethoxychromen-2-one_major
methyl (4bR,10aR,12aS)-6-hydroxy-3,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,5,8-tetraoxo-10b,11-dihydronaphtho[2,1-f]isochromene-4a-carboxylate_major
methyl (4bR,10aR,12aS)-6-hydroxy-3,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,5,8-tetraoxo-10b,11-dihydronaphtho[2,1-f]isochromene-4a-carboxylate_55.1\\%
methyl (4bR,10aR,12aS)-6-hydroxy-3,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,5,8-tetraoxo-10b,11-dihydronaphtho[2,1-f]isochromene-4a-carboxylate_52.5\\%
methyl (4bR,10aR,12aS)-6-hydroxy-3,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,5,8-tetraoxo-10b,11-dihydronaphtho[2,1-f]isochromene-4a-carboxylate_14.4\\%
6-[2-hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5,7-dimethoxychromen-2-one_68.0\\%
Ala Cys Phe Met
Ala Cys Met Phe
Ala Asp Glu His
Ala Asp His Glu
Ala Glu Asp His
Ala Glu His Asp
Ala Phe Cys Met
Ala Phe Met Cys
Ala His Asp Glu
Ala His Glu Asp
Ala Met Cys Phe
Ala Met Phe Cys
Ala Met Ser Tyr
Ala Met Tyr Ser
Ala Ser Met Tyr
Ala Ser Tyr Met
Ala Tyr Met Ser
Ala Tyr Ser Met
Cys Ala Phe Met
Cys Ala Met Phe
Cys Cys Phe Val
Cys Cys Val Phe
Cys Asp His Pro
C18H26N6O7S (470.15836060000004)
Cys Asp Pro His
C18H26N6O7S (470.15836060000004)
Cys Phe Ala Met
Cys Phe Cys Val
Cys Phe Met Ala
Cys Phe Thr Thr
Cys Phe Val Cys
Cys His Asp Pro
C18H26N6O7S (470.15836060000004)
Cys His Pro Asp
C18H26N6O7S (470.15836060000004)
Cys Met Ala Phe
Cys Met Phe Ala
Cys Pro Asp His
C18H26N6O7S (470.15836060000004)
Cys Pro His Asp
C18H26N6O7S (470.15836060000004)
Cys Ser Val Tyr
Cys Ser Tyr Val
Cys Thr Phe Thr
Cys Thr Thr Phe
Cys Val Cys Phe
Cys Val Phe Cys
Cys Val Ser Tyr
Cys Val Tyr Ser
Cys Tyr Ser Val
Cys Tyr Val Ser
Asp Ala Glu His
Asp Ala His Glu
Asp Cys His Pro
C18H26N6O7S (470.15836060000004)
Asp Cys Pro His
C18H26N6O7S (470.15836060000004)
Asp Glu Ala His
Asp Glu His Ala
Asp His Ala Glu
Asp His Cys Pro
C18H26N6O7S (470.15836060000004)
Asp His Glu Ala
Asp His Pro Cys
C18H26N6O7S (470.15836060000004)
Asp Pro Cys His
C18H26N6O7S (470.15836060000004)
Asp Pro His Cys
C18H26N6O7S (470.15836060000004)
Asp Ser Ser Tyr
C19H26N4O10 (470.16488560000005)
Asp Ser Tyr Ser
C19H26N4O10 (470.16488560000005)
Asp Tyr Ser Ser
C19H26N4O10 (470.16488560000005)
Glu Ala Asp His
Glu Ala His Asp
Glu Asp Ala His
Glu Asp His Ala
Glu Glu Gly His
Glu Glu His Gly
Glu Glu Pro Pro
Glu Gly Glu His
Glu Gly His Glu
Glu His Ala Asp
Glu His Asp Ala
Glu His Glu Gly
Glu His Gly Glu
Glu Pro Glu Pro
Glu Pro Pro Glu
Phe Ala Cys Met
Phe Ala Met Cys
Phe Cys Ala Met
Phe Cys Cys Val
Phe Cys Met Ala
Phe Cys Thr Thr
Phe Cys Val Cys
Phe Met Ala Cys
Phe Met Cys Ala
Phe Met Ser Ser
Phe Ser Met Ser
Phe Ser Ser Met
Phe Thr Cys Thr
Phe Thr Thr Cys
Phe Val Cys Cys
Gly Glu Glu His
Gly Glu His Glu
Gly His Glu Glu
Gly Met Thr Tyr
Gly Met Tyr Thr
Gly Thr Met Tyr
Gly Thr Tyr Met
Gly Tyr Met Thr
Gly Tyr Thr Met
His Ala Asp Glu
His Ala Glu Asp
His Cys Asp Pro
C18H26N6O7S (470.15836060000004)
His Cys Pro Asp
C18H26N6O7S (470.15836060000004)
His Asp Ala Glu
His Asp Cys Pro
C18H26N6O7S (470.15836060000004)
His Asp Glu Ala
His Asp Pro Cys
C18H26N6O7S (470.15836060000004)
His Glu Ala Asp
His Glu Asp Ala
His Glu Glu Gly
His Glu Gly Glu
His Gly Glu Glu
His Met Pro Ser
His Met Ser Pro
His Asn Asn Ser
His Asn Ser Asn
His Pro Cys Asp
C18H26N6O7S (470.15836060000004)
His Pro Asp Cys
C18H26N6O7S (470.15836060000004)
His Pro Met Ser
His Pro Ser Met
His Ser Met Pro
His Ser Asn Asn
His Ser Pro Met
Met Ala Cys Phe
Met Ala Phe Cys
Met Ala Ser Tyr
Met Ala Tyr Ser
Met Cys Ala Phe
Met Cys Phe Ala
Met Phe Ala Cys
Met Phe Cys Ala
Met Phe Ser Ser
Met Gly Thr Tyr
Met Gly Tyr Thr
Met His Pro Ser
Met His Ser Pro
Met Pro His Ser
Met Pro Ser His
Met Ser Ala Tyr
Met Ser Phe Ser
Met Ser His Pro
Met Ser Pro His
Met Ser Ser Phe
Met Ser Tyr Ala
Met Thr Gly Tyr
Met Thr Tyr Gly
Met Tyr Ala Ser
Met Tyr Gly Thr
Met Tyr Ser Ala
Met Tyr Thr Gly
Asn His Asn Ser
Asn His Ser Asn
Asn Asn His Ser
Asn Asn Ser His
Asn Ser His Asn
Asn Ser Asn His
Pro Cys Asp His
C18H26N6O7S (470.15836060000004)
Pro Cys His Asp
C18H26N6O7S (470.15836060000004)
Pro Asp Cys His
C18H26N6O7S (470.15836060000004)
Pro Asp His Cys
C18H26N6O7S (470.15836060000004)
Pro Glu Glu Pro
Pro Glu Pro Glu
Pro His Cys Asp
C18H26N6O7S (470.15836060000004)
Pro His Asp Cys
C18H26N6O7S (470.15836060000004)
Pro His Met Ser
Pro His Ser Met
Pro Met His Ser
Pro Met Ser His
Pro Pro Glu Glu
Pro Ser His Met
Pro Ser Met His
Ser Ala Met Tyr
Ser Ala Tyr Met
Ser Cys Val Tyr
Ser Cys Tyr Val
Ser Asp Ser Tyr
C19H26N4O10 (470.16488560000005)
Ser Asp Tyr Ser
C19H26N4O10 (470.16488560000005)
Ser Phe Met Ser
Ser Phe Ser Met
Ser His Met Pro
Ser His Asn Asn
Ser His Pro Met
Ser Met Ala Tyr
Ser Met Phe Ser
Ser Met His Pro
Ser Met Pro His
Ser Met Ser Phe
Ser Met Tyr Ala
Ser Asn His Asn
Ser Asn Asn His
Ser Pro His Met
Ser Pro Met His
Ser Ser Asp Tyr
C19H26N4O10 (470.16488560000005)
Ser Ser Phe Met
Ser Ser Met Phe
Ser Ser Tyr Asp
C19H26N4O10 (470.16488560000005)
Ser Thr Thr Tyr
Ser Thr Tyr Thr
Ser Val Cys Tyr
Ser Val Tyr Cys
Ser Tyr Ala Met
Ser Tyr Cys Val
Ser Tyr Asp Ser
C19H26N4O10 (470.16488560000005)
Ser Tyr Met Ala
Ser Tyr Ser Asp
C19H26N4O10 (470.16488560000005)
Ser Tyr Thr Thr
Ser Tyr Val Cys
Thr Cys Phe Thr
Thr Cys Thr Phe
Thr Phe Cys Thr
Thr Phe Thr Cys
Thr Gly Met Tyr
Thr Gly Tyr Met
Thr Met Gly Tyr
Thr Met Tyr Gly
Thr Ser Thr Tyr
Thr Ser Tyr Thr
Thr Thr Cys Phe
Thr Thr Phe Cys
Thr Thr Ser Tyr
Thr Thr Tyr Ser
Thr Tyr Gly Met
Thr Tyr Met Gly
Thr Tyr Ser Thr
Thr Tyr Thr Ser
Val Cys Cys Phe
Val Cys Phe Cys
Val Cys Ser Tyr
Val Cys Tyr Ser
Val Phe Cys Cys
Val Ser Cys Tyr
Val Ser Tyr Cys
Val Tyr Cys Ser
Val Tyr Ser Cys
Tyr Ala Met Ser
Tyr Ala Ser Met
Tyr Cys Ser Val
Tyr Cys Val Ser
Tyr Asp Ser Ser
C19H26N4O10 (470.16488560000005)
Tyr Gly Met Thr
Tyr Gly Thr Met
Tyr Met Ala Ser
Tyr Met Gly Thr
Tyr Met Ser Ala
Tyr Met Thr Gly
Tyr Ser Ala Met
Tyr Ser Cys Val
Tyr Ser Asp Ser
C19H26N4O10 (470.16488560000005)
Tyr Ser Met Ala
Tyr Ser Ser Asp
C19H26N4O10 (470.16488560000005)
Tyr Ser Thr Thr
Tyr Ser Val Cys
Tyr Thr Gly Met
Tyr Thr Met Gly
Tyr Thr Ser Thr
Tyr Thr Thr Ser
Tyr Val Cys Ser
Tyr Val Ser Cys
7-Hydroxymethotrexate
D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists
4-(5,7-Dimethoxy-2-oxo-2H-chromen-6-yl)-3-hydroxy-2-methyl-2-butanyl ?-D-glucopyranoside
1-[[2-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester
Moexiprilat
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor
N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide
LK-PENICILLIN IN PENICILLIN G THE DERIVATIVES
C24H26N2O6S (470.15114960000005)
(S)-2-((S)-2-(((R)-1-Carboxy-3-phenylpropyl)amino)propanoyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
1-N,4-N-bis(3,5-dimethoxyphenyl)-3,6-dimethyl-1,2,4,5-tetrazine-1,4-dicarboxamide
methyl (2Z,5Z)-7-[(2R)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hepta-2,5-dienoate
(2R)-1,1,1-Trifluoro-4-[2-methoxy-5-(5-pyrimidinyl)phenyl]-4-meth yl-2-(1H-pyrrolo[2,3-c]pyridin-2-ylmethyl)-2-pentanol
C25H25F3N4O2 (470.19295059999996)
2-(4-Diphenylmethyl-1-piperazinyl)ethyl Acetoacetate Oxalate
Docarpamine
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist
Imiglitazar
C28H26N2O5 (470.18416260000004)
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist
7-[2-(1,3-Benzothiazol-2-ylthio)ethyl]-1,3-dimethyl-8-(3-methyl-1-piperidinyl)purine-2,6-dione
N-(2-furanylmethyl)-2-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide
C24H26N2O6S (470.15114960000005)
Cormethasone acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
O-(3-O-beta-D-galactosyl-N-acetyl-alpha-D-galactosaminyl)-L-serine
A serine derivative that is L-serine having a 3-O-beta-D-galactosyl-N-acetyl-alpha-D-galactosaminyl moiety attached to the side-chain oxygen.
N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine
C24H27ClN4O4 (470.17207320000006)
116964-16-0
(E)-4-[4-(5-methyl-2-phenyl-4-oxazolylmethoxy)benzyloxyimino]-4-phenylbutyric acid
C28H26N2O5 (470.18416260000004)
Alvaradoin K
A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 2-O-senecioyl-alpha-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10R stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.
5-Formimidoyltetrahydrofolate(2-)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
5-[2-(6-Hydroxy-4,7-dimethoxy-1-benzofuran-5-yl)-2-oxoethyl]-4-methoxy-6,6-dimethyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-6-ium
3-[2-(tert-butylamino)-2-oxoethoxy]-N-(4-chloro-2,5-dimethoxyphenyl)-2-naphthalenecarboxamide
C25H27ClN2O5 (470.16084020000005)
4-[[3-[2-(1-cyclohexenyl)ethyl]-4-oxo-2-sulfanylidene-1H-quinazolin-7-yl]-oxomethyl]-1-piperazinecarboxylic acid ethyl ester
C24H30N4O4S (470.19876600000003)
[4-[(2-Chlorophenyl)methyl]-1-piperazinyl]-(6,8-dimethyl-2-pyridin-4-yl-4-quinolinyl)methanone
4-(3,5-dimethyl-1-pyrazolyl)-N-[2-methoxy-5-(4-morpholinylsulfonyl)phenyl]benzamide
C23H26N4O5S (470.16238260000006)
methyl 3-[3-[4-(3-chlorophenyl)piperazin-1-yl]propanoylamino]-4-methoxy-1H-indole-2-carboxylate
C24H27ClN4O4 (470.17207320000006)
N-[[(4S,5S)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
O-(3-O-D-galactosyl-N-acetyl-beta-D-galactosaminyl)-L-serine
A derivative of L-serine having a 3-O-D-galactosyl-N-acetyl-beta-D-galactosaminyl moiety attached to the side-chain oxygen.
(3E,5R)-5-[(1R,5R,6Z,9Z,13R,15R)-5-(acetyloxy)-10-chloro-6-methyl-3-oxo-2,14-dioxabicyclo[11.2.1]hexadeca-6,9-dien-15-yl]-5-hydroxy-3-methylpent-3-enoic acid
N-[[(4S,5S)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
(6R,7R,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6R,7S,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6R,7R,8R)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6R,7S,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6R,7R,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6S,7S,8S)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O5 (470.18416260000004)
N-[[(4R,5S)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5R)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5S)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4S,5R)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5R)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4S,5R)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-methoxyphenyl)methyl]acetamide
[(3aR,4S,9bS)-4-(hydroxymethyl)-8-[2-(3-methoxyphenyl)ethynyl]-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-(2-fluorophenyl)methanone
(3S)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-4-[3-(3-hydroxy-3-methylbut-1-ynyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxylic acid
C25H30N2O5S (470.18753300000003)
(6S,7S,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6R,7S,8R)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6S,7R,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6S,7S,8R)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6S,7R,8R)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[2-(3-pyridinyl)ethynyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C27H23FN4O3 (470.17540999999994)
(6S,7S,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6R,7R,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6R,7S,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6S,7R,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6S,7R,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6S,7S,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H27FN2O4S (470.16754740000005)
(6R,7R,8S)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O5 (470.18416260000004)
(6S,7S,8R)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O5 (470.18416260000004)
D-Galactosyl-3-(N-acetyl-beta-D-galactosaminyl)-L-serine
(2S)-3-(2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-alpha-D-galactopyranosyloxy)-2-azaniumylpropanoate
methyl 2-[(5E)-5-[(3,4-diethoxyphenyl)methylidene]-3-(4-methoxyphenyl)-4-oxo-2-sulfanylideneimidazolidin-1-yl]acetate
C24H26N2O6S (470.15114960000005)
[(2->6)-alpha-D-glucosyl-(1->4)-N-acetyl-alpha-D-neuraminosyl]n
(2S,3S,4S,5R)-6-[1-[[3,5-bis(2-cyanopropan-2-yl)phenyl]methyl]-1,2,4-triazol-4-ium-4-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid
C23H28N5O6+ (470.20394880000003)
5-Formimidoyltetrahydrofolate(2-)
Dianion of 5-formimidoyltetrahydrofolic acid arising from deprotonation of both carboxylic acid functions.
FR177391
A 14-membered macrolide isolated from the Serratia liquefaciens and exhibits anti-hyperlipidemic activity.
O-(3-O-D-galactosyl-N-acetyl-beta-D-galactosaminyl)-L-serine zwitterion
Zwitterionic form of O-(3-O-D-galactosyl-N-acetyl-beta-D-galactosaminyl)-L-serine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.
O-(3-O-beta-D-galactosyl-N-acetyl-alpha-D-galactosaminyl)-L-serine zwitterion
An amino acid zwitterion that is the zwitterionic form of O-(3-O-beta-D-galactosyl-N-acetyl-alpha-D-galactosaminyl)-L-serine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.
AZD1283
C23H26N4O5S (470.16238260000006)
AZD1283 is a potent P2Y12 receptor antagonist with a binding IC50 of 11 nM and a GTPγS IC50 of 25 nM. AZD1283 has excellent antiplatelet aggregation potency. AZD1283 can be used to research thromboembolic disorders[1][2].
SF-22
C28H26N2O3S (470.1664046000001)
SF-22 is a potent and brain-penetrant antagonist of neuropeptide Y receptor (Y2R), with the IC50 value of 750 nM. SF-22 plays an important role in neurological disease[1].
(1s,2r,4s,7s,8s,11r,12s,18r,20r)-7-(furan-3-yl)-20-hydroxy-1,8,12,17,17-pentamethyl-3,6,16-trioxapentacyclo[9.9.0.0²,⁴.0²,⁸.0¹²,¹⁸]icos-13-ene-5,10,15-trione
methyl (2s,4as,10as,10br)-6-hydroxy-2,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,5,8-tetraoxo-2h,10bh,11h-phenanthro[1,2-c]pyran-4a-carboxylate
methyl 6-hydroxy-2,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,5,8-tetraoxo-2h,10bh,11h-phenanthro[1,2-c]pyran-4a-carboxylate
(2r,3s)-10-[(2s)-2,3-dihydroxy-3-methylbutyl]-3,5-dihydroxy-2-(4-methoxyphenyl)-8,8-dimethyl-2h,3h-pyrano[3,2-g]chromen-4-one
6,9-dihydroxy-9-methyl-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-8,10-dihydro-7h-tetracene-5,12-dione
18-(methoxymethyl)-1,5-dimethyl-6,11,16-trioxo-13,17-dioxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-2(10),12(19),14-trien-3-yl 2-methylbutanoate
(1s,2r,7s,10r,13r,14r,16s,19s,20s)-19-(furan-3-yl)-9,9,13,20-tetramethyl-4,8,15,18-tetraoxahexacyclo[11.9.0.0²,⁷.0²,¹⁰.0¹⁴,¹⁶.0¹⁴,²⁰]docosane-5,12,17-trione
(2z)-1-[(8s,9r,10r)-3,9-dihydroxy-4,5,19-trimethoxy-10-methyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl]-2-methylbut-2-en-1-one
(1r,3s,6s,7s,11s)-6-(furan-3-yl)-11-[(1s,3r,5r)-1-hydroxy-1,6,6-trimethyl-8-oxo-2,7-dioxaspiro[4.5]dec-9-en-3-yl]-7,11-dimethyl-2,5-dioxatricyclo[5.4.0.0¹,³]undec-9-en-4-one
11-{3a-acetyl-4,4-dimethyl-6-oxo-tetrahydrofuro[3,2-c]pyran-2-yl}-6-(furan-3-yl)-7,11-dimethyl-2,5-dioxatricyclo[5.4.0.0¹,³]undec-9-en-4-one
11,12-dimethyl (1s,12r,15s,20s)-19-formyl-22-oxo-6,8-dioxa-11,19-diazahexacyclo[13.5.3.0¹,¹².0²,¹⁰.0⁵,⁹.0¹⁵,²⁰]tricosa-2(10),3,5(9)-triene-11,12-dicarboxylate
(1r,3s,6s,7s,11s)-6-(furan-3-yl)-11-[(1s,3s,5r)-1-hydroxy-1,6,6-trimethyl-8-oxo-2,7-dioxaspiro[4.5]dec-9-en-3-yl]-7,11-dimethyl-2,5-dioxatricyclo[5.4.0.0¹,³]undec-9-en-4-one
(4s,6r,6as,9r,10s,10as)-6,10-bis(acetyloxy)-6a,9-dihydroxy-3-(methoxymethyl)-6,9-dimethyl-2-oxo-4h,5h,7h,8h,10h-naphtho[4a,4-b]furan-4-yl acetate
[(1z,4s,5s,6r,7e,9e,11e)-6-hydroxy-1-[(2r,3s)-3-hydroxy-6-oxo-2,3-dihydropyran-2-yl]-5-methylheptadeca-1,7,9,11-tetraen-4-yl]oxysulfonic acid
C23H34O8S (470.19742840000004)